CRWV insider 10b5-1 sales continue; 375,000 shares planned for 09/23/2025

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) Form 144: The filer notifies a proposed sale of 375,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $49,961,250 and an approximate sale date of 09/23/2025. The shares were acquired as founders shares on 11/13/2017. The filing lists multiple prior Rule 10b5-1 sales by the same parties during August and September 2025 totaling 3,125,000 shares sold across five dates. The issuer has 370,470,348 shares outstanding as reported in this notice. The filer certifies no undisclosed material adverse information and references reliance on Rule 10b5-1 trading plans where applicable.

Positive

• Seller acquired shares in 2017 as founders shares, indicating long-term holding prior to disposals
• Sale routed through a major broker (Morgan Stanley Smith Barney), suggesting orderly execution
• Filer certifies no undisclosed material adverse information and documents 10b5-1 plan reliance where applicable

Negative

• Significant recent insider sales are documented: 3,125,000 shares sold via 10b5-1 plans in AugSep 2025, increasing share supply to the market

Insights

Securities Analyst

TL;DR: Founder-origin shares planned for sale through an established broker under a 10b5-1 plan; prior sales show recurring liquidity events.

This Form 144 records a proposed sale of 375,000 common shares valued at $49.96 million, executed through Morgan Stanley Smith Barney. The securities were acquired as founders shares in 2017, indicating long-term ownership prior to these dispositions. The filing also documents five recent 10b5-1 sale dates in Aug–Sep 2025 totaling 3,125,000 shares sold. For investors, repeating 10b5-1 transactions increase share supply near the market, but the filing itself follows standard regulatory mechanics rather than announcing corporate changes.

Corporate Governance Expert

TL;DR: Routine insider disposition under Rule 144/10b5-1 with required certification; governance disclosure appears compliant.

The notice discloses the sellers representation that no material nonpublic adverse information exists and references plan adoption dates where applicable. The shares to be sold are identified as founders shares acquired in 2017, and the broker is named. The document provides required transparency about recent insider sales and the outstanding share count, which supports market disclosure and regulatory compliance. No corporate governance actions or changes are reported in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	375000	49961250.00	370470348	09/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			375000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/16/2025	250000	29542575.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/16/2025	375000	44313862.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	250000	24866825.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	375000	37301250.00
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	250000	23292325.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	375000	34938487.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	250000	22996925.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	375000	34495387.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	250000	22926475.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	375000	34389712.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CoreWeaves Form 144 (CRWV) disclose about the proposed sale?

The notice discloses a proposed sale of 375,000 common shares with an aggregate market value of $49,961,250, to be sold through Morgan Stanley Smith Barney around 09/23/2025.

When were the shares to be sold originally acquired?

The shares were acquired as founders shares on 11/13/2017 and the filing shows the acquisition source as the issuer.

Has the seller made other sales recently?

Yes. The filing lists multiple Rule 10b5-1 sales on 08/19, 08/26, 09/02, 09/09, and 09/16/2025 totaling 3,125,000 shares sold in the past three months.

How many CoreWeave shares are outstanding according to the filing?

The notice reports 370,470,348 shares outstanding for the issuer in this filing.

Who is the broker handling the proposed sale?

The proposed sale is to be executed by Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY.